Back

Voclosporin Preserves Mitochondrial Function Compared With Cyclosporine A in Perfused Human Proximal Tubule Microphysiological Systems

Aryeh, K. S.; Tsang, Y. P.; Hsu, E. W.; Yeung, C. K.; MacDonald, J.; Bammler, T. K.; Himmelfarb, J.; Rehaume, L. M.; Kelly, E. J.

2026-07-11 pharmacology and toxicology
10.64898/2026.07.07.737071 bioRxiv
Show abstract

Key PointsO_LIPerfused human kidney MPS revealed CsA-associated sublethal tubular stress that was not detected by conventional 2D viability assays or by KIM-1 release in 3D MPS. C_LIO_LIAt matched exposure, VCS preserved mitochondria and activated ER chaperones and iron detoxification, with no p21 arrest compared to CsA. C_LIO_LIMechanistic separation supports VCSs nephroprotection potential and early mechanism-based biomarkers to guide CNI choice. C_LI O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=113 SRC="FIGDIR/small/737071v1_ufig1.gif" ALT="Figure 1"> View larger version (46K): org.highwire.dtl.DTLVardef@e5e01dorg.highwire.dtl.DTLVardef@1dc9167org.highwire.dtl.DTLVardef@1ce22f8org.highwire.dtl.DTLVardef@5a053a_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical AbstractC_FLOATNO C_FIG BackgroundCalcineurin inhibitors (CNIs) are indispensable for transplantation immunosuppression, yet cyclosporine A (CsA) produces renal toxicity. Voclosporin (VCS), a CsA analog, is proposed to be less nephrotoxic, but mechanisms remain unclear. MethodsPrimary human proximal tubule epithelial cells (PTECs) were exposed to CsA or VCS in 2D monolayers and perfused 3D kidney microphysiological system (MPS). Viability was assessed in 2D cultures by MTS, mitochondrial membrane potential ({Delta}{Psi}m) by TMRM flow cytometry, and soluble injury and inflammatory biomarkers in MPS effluents by ELISA and MSD multiplex assays. RNA sequencing of 3D-cultured PTECs was used to identify differentially expressed genes and pathways. ResultsIn 2D PTECs, neither drug reduced viability. In 3D MPS effluents, KIM-1 did not distinguish CsA from VCS, whereas the MSD biomarker panel showed larger aggregate deviation with CsA. Confocal tomography showed CsA-associated mitochondrial fragmentation, whereas VCS preserved reticular mitochondrial architecture. TMRM flow cytometry showed a treatment-dependent difference in TMRM-positive cells, with VCS yielding the highest TMRM-positive fraction and exceeding CsA, supporting preservation of {Delta}{Psi}m relative to CsA. RNA-seq identified 1188 CsA-specific and 185 VCS-specific differentially expressed genes, with 304 shared. Pathway analysis indicated CsA enrichment of unfolded protein response (UPR) and endoplasmic reticulum (ER) stress, p21-associated G2/M checkpoint arrest, and transcriptional signatures consistent with ferroptosis priming, while VCS mainly induced ER chaperone and ER-associated degradation gene programs without activating canonical UPR sensors and showed limited cell-cycle suppression. ConclusionsA physiologically relevant 3D kidney MPS revealed sublethal tubular stress from CsA that is masked in 2D culture, including mitochondrial depolarization, proteostatic stress, and ferroptosis priming. At matched exposure, VCS preserved mitochondrial function and proteostasis while eliciting a narrower, adaptive ER quality control response. These data support VCS as a nephron-sparing immunosuppressant and 3D MPS as a mechanism-based platform for evaluating renal safety of drugs and nominating early sub-lethal tubular injury biomarkers.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of the American Society of Nephrology
56 papers in training set
Top 0.2%
9.7%
2
Frontiers in Pharmacology
111 papers in training set
Top 0.2%
7.9%
3
PLOS ONE
5266 papers in training set
Top 24%
6.8%
4
JCI Insight
277 papers in training set
Top 0.7%
6.8%
5
American Journal of Physiology-Renal Physiology
28 papers in training set
Top 0.1%
5.6%
6
American Journal of Transplantation
18 papers in training set
Top 0.1%
4.9%
7
Archives of Toxicology
18 papers in training set
Top 0.1%
4.3%
8
Kidney360
22 papers in training set
Top 0.2%
4.1%
50% of probability mass above
9
Kidney International
29 papers in training set
Top 0.2%
4.1%
10
Toxicological Sciences
41 papers in training set
Top 0.2%
2.4%
11
Journal of Translational Medicine
57 papers in training set
Top 0.4%
2.4%
12
Kidney International Reports
15 papers in training set
Top 0.2%
2.1%
13
Scientific Reports
3612 papers in training set
Top 47%
2.1%
14
Antimicrobial Agents and Chemotherapy
187 papers in training set
Top 1%
1.7%
15
British Journal of Pharmacology
40 papers in training set
Top 0.4%
1.7%
16
eBioMedicine
183 papers in training set
Top 3%
1.7%
17
Clinical and Translational Science
22 papers in training set
Top 0.3%
1.4%
18
Transplantation
13 papers in training set
Top 0.1%
1.4%
19
BMC Nephrology
18 papers in training set
Top 0.2%
1.3%
20
Cells
249 papers in training set
Top 5%
1.1%
21
Stem Cell Reports
130 papers in training set
Top 1%
1.1%
22
The Journal of Pharmacology and Experimental Therapeutics
18 papers in training set
Top 0.3%
1.1%
23
Frontiers in Immunology
638 papers in training set
Top 8%
1.1%
24
The FASEB Journal
194 papers in training set
Top 5%
1.0%
25
Fluids and Barriers of the CNS
28 papers in training set
Top 0.5%
0.8%
26
The Journal of Infectious Diseases
202 papers in training set
Top 4%
0.8%
27
Nature Communications
5641 papers in training set
Top 56%
0.8%
28
Clinical and Translational Medicine
31 papers in training set
Top 0.8%
0.8%
29
Cell Death Discovery
58 papers in training set
Top 2%
0.6%
30
Diabetologia
44 papers in training set
Top 0.8%
0.6%